Literature DB >> 27661655

Practice Bulletin No. 172: Premature Rupture of Membranes.

.   

Abstract

Preterm delivery occurs in approximately 12% of all births in the United States and is a major factor that contributes to perinatal morbidity and mortality (1, 2). Preterm premature rupture of membranes (PROM) complicates approximately 3% of all pregnancies in the United States (3). The optimal approach to clinical assessment and treatment of women with term and preterm PROM remains controversial. Management hinges on knowledge of gestational age and evaluation of the relative risks of delivery versus the risks of expectant management (eg, infection, abruptio placentae, and umbilical cord accident). The purpose of this document is to review the current understanding of this condition and to provide management guidelines that have been validated by appropriately conducted outcome-based research when available. Additional guidelines on the basis of consensus and expert opinion also are presented.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27661655     DOI: 10.1097/AOG.0000000000001712

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

1.  Latency period of PROM at term and the risk of neonatal infectious diseases.

Authors:  Lu Zhuang; Zhan-Kui Li; Yuan-Fang Zhu; Rong Ju; Shao-Dong Hua; Chun-Zhi Yu; Xing Li; Yan-Ping Zhang; Lei Li; Yan Yu; Wen Zeng; Jie Cui; Xin-Yu Chen; Jing-Ya Peng; Ting Li; Zhi-Chun Feng
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

2.  Effects of Anticoagulants and Immune Agents on Pregnancy Outcomes and Offspring Safety in Frozen-Thawed Embryo Transfer Cycles-A Retrospective Cohort Study.

Authors:  Yanli Fan; Yizhuo Wang; Zhuoye Luo; Yueming Xu; Jie Zhang; Wei Wang; Na Cui; Guimin Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-21       Impact factor: 6.055

3.  Tenascin-X in amniotic fluid and reproductive tissues of pregnancies complicated by infection and preterm prelabor rupture of membranes†.

Authors:  Kara M Rood; Catalin S Buhimschi; Guomao Zhao; Emily A Oliver; Taryn Summerfield; Mert Ozan Bahtiyar; Irina A Buhimschi
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

4.  Short interpregnancy interval increases the risk of preterm premature rupture of membranes and early delivery.

Authors:  Raj Shree; Aaron B Caughey; Suchitra Chandrasekaran
Journal:  J Matern Fetal Neonatal Med       Date:  2017-08-09

5.  Cesarean section and pregnancy outcomes of preterm premature rupture of membranes under different fertility policies in China.

Authors:  Haili Jiang; Chang Lu; Jianxin Zhou; Weiyuan Zhang
Journal:  Transl Pediatr       Date:  2021-04

6.  An extremely rare case of hand prolapse with preterm premature rupture in the membrane of one twin.

Authors:  Minji Kim; Hye-Joo Lee; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2018-04-11

7.  Components of the antepartum, intrapartum, and postpartum exposome impact on distinct short-term adverse neonatal outcomes of premature infants: A prospective cohort study.

Authors:  Unzila Ali Nayeri; Catalin S Buhimschi; Guomao Zhao; Irina A Buhimschi; Vineet Bhandari
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

8.  Labor induction in term nulliparous women with premature rupture of membranes: oxytocin versus dinoprostone.

Authors:  Nur Gozde Kulhan; Mehmet Kulhan
Journal:  Arch Med Sci       Date:  2018-06-01       Impact factor: 3.318

9.  A new rapid bedside test to diagnose and monitor intraamniotic inflammation in preterm PROM using transcervically collected fluid.

Authors:  Kyung Joon Oh; JoonHo Lee; Roberto Romero; Hyun Soo Park; Joon-Seok Hong; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2020-02-27       Impact factor: 10.693

10.  Collagen Type 1 Accelerates Healing of Ruptured Fetal Membranes.

Authors:  Haruta Mogami; Annavarapu Hari Kishore; R Ann Word
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.